Skip to main content
Clinical Trials/NCT02184728
NCT02184728CompletedNot Applicable

Comparison of End-tidal Carbon Dioxide (ETCO2) Measured by Transportable Capnometer (EMMATM) and the Arterial pCO2 in General Anesthesia

Inje University1 site in 1 country35 target enrollmentStarted: June 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
35
Locations
1
Primary Endpoint
End-tidal CO2

Study Overview

Brief Summary

An end-tidal CO 2 monitor (capnometer) is used most often as a noninvasive substitute for PaCO2 in anesthesia, anesthetic recovery and intensive care. There is now also wide-spread use of capnometry on-site at emergency and trauma fields. So, portable device can be used usefully.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Masking
None

Eligibility Criteria

Ages
20 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients who anticipated arterial gas analyze intraoperatively

Exclusion Criteria

  • •patients who didn't get arterial line

Arms & Interventions

EMMA(TM)

No Intervention

A small capnograph for measuring ET-CO2 - the EMMA capnometer

1

Intervention: End-tidal CO2(portable capnometer) (Device)

Outcomes

Primary Outcomes

End-tidal CO2

Time Frame: During operation (2-4 times)

End-tidal CO2(portable capnometer: EMMATM, Side stream capnometry module:Datex-Ohmeda S5 Anesthesia Monitor )levels were recorded at the time of arterial blood gas sampling.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sira Bang

Assistant Professor

Inje University

Study Sites (1)

Loading locations...

Similar Trials